Clinical Trial Update: Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating growth hormone treatment in adult patients with chronic kidney disease, including end-stage renal disease, has completed. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Growth Hormone (Somatropin) (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Chronic Kidney Disease, End-Stage Renal Disease | Phase 2 | Status: COMPLETED